NEONET
LIVE

Serial Number

87581872

Owner

NeoGenomics Laboratories, Inc.

Attorney

Anessa O. Kramer

Filing Date

Aug 24, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NEONET Trademark

Serial Number: 87581872 • Registration: 6356240

NEONET is a trademark filed by NeoGenomics Laboratories, Inc. on August 24, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

NeoGenomics Laboratories, Inc.

9490 NeoGenomics Way
Fort Myers, FL 33912

Entity Type: 03

Trademark Details

Filing Date

August 24, 2017

Registration Date

May 18, 2021

Published for Opposition

January 30, 2018

Goods & Services

Genetic mapping for scientific purposes; gene sequencing; molecular sequencing; cancer study and analysis; clinical study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells, and cancer; providing information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology ; genetic testing, rna testing and sequencing; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory services, oncology reference laboratory services, providing information, interactive information, and reports, to others in the field of pathology, diagnostic testing, oncology testing; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; providing an interactive website that allows users to enter, access, and synthesize information and generate reports pertaining to medical and scientific testing and analysis; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing information in the field of oncology; providing laboratory information for medical and scientific purposes

Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; oncology reference laboratory services; medical and scientific information services, namely, providing information in the field of medical testing, clinical testing, scientific research, reporting of clinical testing results directly to the patient; providing medical information; providing medical testing information; providing scientific information in the field of human disease and medical testing in relation thereto

Compilation and systemization of information into computer database(s)

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 18, 2026 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 1, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 1, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 1, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 1, 2023 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 10, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 10, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 10, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 10, 2022 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 13, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
May 18, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 14, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 13, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 31, 2021 SUPC
USE AMENDMENT FILED
Mar 26, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 26, 2021 EISU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 26, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 26, 2021 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 22, 2020 EXRA
SOU EXTENSION 5 GRANTED
Sep 21, 2020 EX5G
SOU EXTENSION 5 FILED
Sep 16, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 16, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 16, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 16, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 16, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 16, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 16, 2020 COAR
ASSIGNED TO EXAMINER
Jul 23, 2020 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2020 EXRA
SOU EXTENSION 4 GRANTED
Feb 3, 2020 EX4G
SOU EXTENSION 4 FILED
Jan 31, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 31, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 27, 2019 EXRA
SOU EXTENSION 3 GRANTED
Sep 26, 2019 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 26, 2019 AITU
SOU EXTENSION 3 FILED
Sep 23, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 23, 2019 EEXT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 3, 2019 ASCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2019 EXRA
SOU EXTENSION 2 GRANTED
Feb 25, 2019 EX2G
SOU EXTENSION 2 FILED
Feb 25, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 25, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 29, 2018 EXRA
SOU EXTENSION 1 GRANTED
May 25, 2018 EX1G
SOU EXTENSION 1 FILED
May 25, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
May 25, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 27, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 23, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 18, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 18, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 18, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2017 CRFA
ASSIGNED TO LIE
Dec 15, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 2, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 2, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 2, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 29, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2017 NWOS
NEW APPLICATION ENTERED
Aug 28, 2017 NWAP